Immutep Ltd
ASX:IMM
Immutep Ltd
ASX:IMM
Price:
0.44 AUD
Market Closed
Updated:
May 30, 2024
Immutep Ltd
EPS (Diluted)
|
Immutep Ltd
EPS (Diluted) Peer Comparison
Comparables:
MSB
CSL
CUV
TLX
PYC
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Immutep Ltd
ASX:IMM
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
|
Mesoblast Ltd
ASX:MSB
|
EPS (Diluted)
$0
|
CAGR 3-Years
21%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
EPS (Diluted)
$5
|
CAGR 3-Years
-4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Immutep Ltd's EPS (Diluted)?
EPS (Diluted)
-0
AUD
-0
AUD
Based on the financial report for Dec 31, 2023, Immutep Ltd's EPS (Diluted) amounts to -0 AUD.
What is Immutep Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
10%
10%
Over the last year, the EPS (Diluted) growth was 0%. The average annual EPS (Diluted) growth rates for Immutep Ltd have been 13% over the past three years , 8% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
